XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Millions
Total
Convertible preferred stock
Class A and Class B common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred shares outstanding, beginning of the period (in shares)   0        
Beginning balance at Dec. 31, 2021 $ (293.9) $ 0.0 $ 0.0 $ 2,448.1 $ (2,739.4) $ (2.6)
Beginning balance (in shares) at Dec. 31, 2021     375,500,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Release of restricted stock units and awards (in shares)     14,400,000      
Shares withheld related to net share settlement of restricted stock units and awards (in shares) (5,300,000)   (5,100,000)      
Shares withheld related to net share settlement of restricted stock units and awards $ (119.4)     (41.5) (77.9)  
Repurchases of common stock (in shares)     (35,600,000)      
Repurchases of common stock $ (795.4)     (287.4) (508.0)  
Exercise of stock options and awards (in shares) 200,000   200,000      
Exercise of stock options and awards $ 0.5     0.5    
Tax benefit attributable to bond hedges purchased in connection with issuance of convertible senior notes 61.2     61.2    
Stock-based compensation 330.7     330.7    
Other comprehensive income (loss) (46.3)         (46.3)
Net income 553.2       553.2  
Preferred shares outstanding, end of the period (in shares) at Dec. 31, 2022   0        
Ending balance at Dec. 31, 2022 (309.4) $ 0.0 $ 0.0 2,511.6 (2,772.1) (48.9)
Ending balance (in shares) at Dec. 31, 2022     349,400,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred shares outstanding, beginning of the period (in shares)   0        
Release of restricted stock units and awards (in shares)     15,100,000      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)     (5,300,000)      
Shares withheld related to net share settlement of restricted stock units and awards (135.1)     (48.5) (86.6)  
Repurchases of common stock (in shares)     (22,700,000)      
Repurchases of common stock (542.8)     (205.6) (337.2)  
Exercise of stock options and awards (in shares)     200,000      
Exercise of stock options and awards 2.5     2.5    
Stock-based compensation 338.0     338.0    
Other comprehensive income (loss) 27.4         27.4
Net income $ 453.6       453.6  
Preferred shares outstanding, end of the period (in shares) at Dec. 31, 2023 0 0        
Ending balance at Dec. 31, 2023 $ (165.8) $ 0.0 $ 0.0 2,598.0 (2,742.3) (21.5)
Ending balance (in shares) at Dec. 31, 2023     336,700,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred shares outstanding, beginning of the period (in shares) 0 0        
Release of restricted stock units and awards (in shares)     14,400,000      
Shares withheld related to net share settlement of restricted stock units and awards (in shares) (5,700,000)   (5,700,000)      
Shares withheld related to net share settlement of restricted stock units and awards $ (148.7)     (55.2) (93.5)  
Repurchases of common stock (in shares)     (49,500,000)      
Repurchases of common stock $ (1,248.9)     (485.9) (763.0)  
Exercise of stock options and awards (in shares) 100,000   100,000      
Exercise of stock options and awards $ 0.9     0.9    
Stock-based compensation 346.5     346.5    
Other comprehensive income (loss) 11.4         11.4
Net income $ 452.3       452.3  
Preferred shares outstanding, end of the period (in shares) at Dec. 31, 2024 0 0        
Ending balance at Dec. 31, 2024 $ (752.4) $ 0.0 $ 0.0 $ 2,404.2 $ (3,146.5) $ (10.1)
Ending balance (in shares) at Dec. 31, 2024     295,900,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred shares outstanding, beginning of the period (in shares) 0 0